Does EMPAGLIFLOZIN\LINAGLIPTIN Cause Diabetic ketoacidosis? 149 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Diabetic ketoacidosis have been filed in association with EMPAGLIFLOZIN\LINAGLIPTIN. This represents 9.2% of all adverse event reports for EMPAGLIFLOZIN\LINAGLIPTIN.
149
Reports of Diabetic ketoacidosis with EMPAGLIFLOZIN\LINAGLIPTIN
9.2%
of all EMPAGLIFLOZIN\LINAGLIPTIN reports
3
Deaths
121
Hospitalizations
How Dangerous Is Diabetic ketoacidosis From EMPAGLIFLOZIN\LINAGLIPTIN?
Of the 149 reports, 3 (2.0%) resulted in death, 121 (81.2%) required hospitalization, and 15 (10.1%) were considered life-threatening.
Is Diabetic ketoacidosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN\LINAGLIPTIN. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN\LINAGLIPTIN Cause?
Blood glucose increased (121)
Fungal infection (92)
Weight decreased (77)
Nausea (68)
Dizziness (58)
Vomiting (55)
Urinary tract infection (52)
Euglycaemic diabetic ketoacidosis (49)
Dehydration (44)
Ketoacidosis (43)
What Other Drugs Cause Diabetic ketoacidosis?
EMPAGLIFLOZIN (3,644)
CANAGLIFLOZIN (3,413)
DAPAGLIFLOZIN (1,773)
METFORMIN (1,584)
INSULIN ASPART (1,398)
INSULIN LISPRO (924)
INSULIN GLARGINE (776)
NIVOLUMAB (687)
DAPAGLIFLOZIN PROPANEDIOL (547)
PEMBROLIZUMAB (397)
Which EMPAGLIFLOZIN\LINAGLIPTIN Alternatives Have Lower Diabetic ketoacidosis Risk?
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL